SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-182717
Filing Date
2019-06-26
Accepted
2019-06-26 17:16:32
Documents
4
Period of Report
2019-06-26

Document Format Files

Seq Description Document Type Size
1 6-K d730878d6k.htm 6-K 8108
2 EX-99.1 d730878dex991.htm EX-99.1 15066
3 GRAPHIC g730878g0626080041271.jpg GRAPHIC 2906
4 GRAPHIC g730878g0626080041505.jpg GRAPHIC 4216
  Complete submission text file 0001193125-19-182717.txt   34452
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 19922375
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences